Closing the Gap in Care in Seronegative Inflammatory Arthritis

Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SpA PsA

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dr. Vandana Ahluwalia, Brampton, Ontario, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Canadian Rheumatologist

Exclusion criteria

Treatment and study plan

Education and Feedback

Behavioral

Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.

Primary outcomes

Improvement of Systematic Assessments

Time frame: November 2012 - November 2013

Physicians in the Education and Feedback arm are assessed via a needs assessment to identify the care gaps for their patients with inflammatory arthritis. After the education and feedback, they complete a second chart audit and their improvements in assessments is recorded.

Sponsors and collaborators

Lead sponsor

Pope Research Corporation

Industry

Collaborators

Abbott
Academic Medical Organization of Southwestern Ontario

Registry information

Official study title

Closing the Gap in Care in Seronegative Inflammatory Arthritis: From Identification to Implementation of Treating to Target: A Randomized Trial of Feedback, Education, and Behavioural Change

Acronym: Metrix II

Important dates

Study start: 2012
Primary completion: 2016
Study completion: 2016
First posted: Dec 17, 2012
Registry last updated: Apr 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed